Cargando…
In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017–2020
To understand the changes of resistance in clinically commonly encountered fungi, we used the Antimicrobial Testing Leadership and Surveillance (ATLAS) database to explore in vitro antifungal susceptibilities against clinically important isolates of Aspergillus and Candida species (collected from in...
Autores principales: | Jean, Shio-Shin, Yang, Hung-Jen, Hsieh, Po-Chuen, Huang, Yu-Tsung, Ko, Wen-Chien, Hsueh, Po-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769544/ https://www.ncbi.nlm.nih.gov/pubmed/36314941 http://dx.doi.org/10.1128/spectrum.02965-22 |
Ejemplares similares
-
In Vitro Antifungal Activity of Three Synthetic Peptides against Candida auris and Other Candida Species of Medical Importance
por: Torres, Richar, et al.
Publicado: (2023) -
Chemical compositions and antifungal activities of Satureja macrosiphon against Candida and Aspergillus species
por: Motamedi, Marjan, et al.
Publicado: (2019) -
Antimicrobial Peptides: Avant-Garde Antifungal Agents to Fight against Medically Important Candida Species
por: Rodríguez-Castaño, Gina P., et al.
Publicado: (2023) -
P002 Antifungal activity of antimicrobial synthetic peptides against Candida species of public health importance
por: Torres, Richar, et al.
Publicado: (2022) -
Biofilm Formation in Medically Important Candida Species
por: Malinovská, Zuzana, et al.
Publicado: (2023)